Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy

Clinical trial NCT06385990 · RECRUITING

Trial details

NCT number: NCT06385990
Sponsor: Hunan Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Neoplasms

Start date: 2024-03-29
Primary completion: 2025-03-29
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.